Pregnancy

Pfizer and BioNTech Receive Positive CHMP Opinion for Conversion of COMIRNATY® Conditional Marketing Authorization to Full Marketing Authorization in the European Union

Standard marketing authorization recommendation applies to all indications and formulations in the European Union, including COMIRNATY® Original/Omicron BA.4-5 and COMIRNATY®…

2 years ago

Philips highlights FetView cloud-based image sharing and reporting software for obstetrics and gynecology at ISUOG 2022

Clinician uses ultrasound in pregnancy assessment Clinician uses Philips ultrasound Philips out-of-hospital fetal ultrasound September 15, 2022 Philips FetView will…

2 years ago

Physician Scientist at Birthing Cultural Rigor Prioritizes Voices of Black Birthing Experience in Response to Obstetric Racism in the United States

MEMPHIS, Tenn., Sept. 14, 2022 (GLOBE NEWSWIRE) -- Black mothers die in hospitals at nearly four times the rate of White mothers…

2 years ago

Ovia Health Recognized by HHS for Program to Improve Birth Equity

Company Extends Focus on Underserved Patients Named a Phase 1 Winner in the HHS Racial Equity and Postpartum Care Challenge…

2 years ago

ObsEva Announces Progress on Restructuring Initiatives

$7.6 million annual savings expected via reduction-in-force currently underway$6.2 million savings expected from assignment of legacy linzagolix program contracts to…

2 years ago

Veru to Present at the H.C. Wainwright 24th Annual Global Investment Conference on September 12th, 2022

MIAMI, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for…

2 years ago

Chembio Diagnostics Awarded $3.2 Million Contract from the CDC for Development and Clinical Validation of Dual-Path Platform Syphilis Screen & Confirm Assay

HAUPPAUGE, N.Y., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Chembio) (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on…

2 years ago

Pfizer and BioNTech Complete Submission to European Medicines Agency for Omicron BA.4/BA.5 Adapted Bivalent Vaccine

Submission follows application for Omicron BA.1-adapted bivalent vaccine submitted in July If authorized, both Omicron BA.1-adapted and Omicron BA.4/5-adapted bivalent…

2 years ago